Central China New Life Limited (CC New Life) reported that every motion tabled at its Annual General Meeting on 1 June 2026 was approved by shareholders through a poll, reflecting near-unanimous support across key items.

Key approvals

1. FY2025 Financial Statements • The audited consolidated financial statements and accompanying reports for the year ended 31 December 2025 were endorsed with 945.29 million votes in favour (99.997%), versus 33,000 votes against (0.003%).

2. Board Composition and Remuneration • Executive Director Mr Yan Xuewen and Independent Non-executive Directors Mr Leong Chong and Ms Luo Laura Ying were all re-elected. • Support levels ranged from 99.92% to 100.00%. • The Board was authorised to determine directors’ remuneration, backed by 99.997% of votes cast.

3. Auditor Re-appointment • Prism Hong Kong Limited was re-appointed as external auditor for the year ending 31 December 2026, with 944.59 million votes in favour (99.92%).

4. Share Issuance and Repurchase Mandates • A general mandate to issue additional shares and an extension thereof both received 98.29% approval. • A separate mandate permitting share repurchases was passed with 100.00% support.

Voting statistics

• Shares in issue and eligible to vote: 1.30 billion. • No shareholders were required to abstain, and no parties signalled an intention to vote against any motion ahead of the meeting. • Computershare Hong Kong Investor Services Limited acted as scrutineer; all directors participated in person or electronically.

Governance outlook

The decisive voting margins reinforce shareholder confidence in CC New Life’s current management team and capital management flexibility as it enters the 2026 financial year.